Lind Global Macro Fund LP 13D and 13G filings for BriaCell Therapeutics Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 5:01 pm Sale | 2021-12-31 | 13G | BriaCell Therapeutics Corp. BCTX | Lind Global Macro Fund LP | 2,443 0.200% | -35,063 (-93.49%) | Filing |
| 2021-02-26 5:02 pm Purchase | 2021-02-26 | 13G | BriaCell Therapeutics Corp. BCTX | Lind Global Macro Fund LP | 37,507 9.900% | 37,507 (New Position) | Filing |